Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells.
about
High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literatureAdvances in Our Understanding of Oxylipins Derived from Dietary PUFAsRole of arachidonic acid lipoxygenase metabolites in the regulation of vascular toneFunctional and pathological roles of the 12- and 15-lipoxygenasesEffect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPARγDeletion of soluble epoxide hydrolase enhances coronary reactive hyperemia in isolated mouse heart: role of oxylipins and PPARγThe pro-resolving lipid mediator maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cellsVascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and ω-HydroxylasesIncreased production of 12/15 lipoxygenase eicosanoids accelerates monocyte/endothelial interactions in diabetic db/db mice.12-Lipoxygenase Products Reduce Insulin Secretion and {beta}-Cell Viability in Human IsletsHyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells.Sphingosine-1-phosphate inhibits high glucose-mediated ERK1/2 action in endothelium through induction of MAP kinase phosphatase-3.Activation of the 12-lipoxygenase and signal transducer and activator of transcription pathway during neointima formation in a model of the metabolic syndrome.Oxidized phospholipids as triggers of inflammation in atherosclerosis.Adhesion of T and B lymphocytes to mouse atherosclerotic aortas: association with lesion topology and VCAM-1 expression.Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation.The natural protective mechanism against hyperglycemia in vascular endothelial cells: roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor deltaPathological aspects of lipid peroxidation.20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteriesDipetalodipin, a novel multifunctional salivary lipocalin that inhibits platelet aggregation, vasoconstriction, and angiogenesis through unique binding specificity for TXA2, PGF2alpha, and 15(S)-HETE.Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascularization.L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in miceCholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone MiceVascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.Disparate effects of 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid in vascular endothelial and smooth muscle cells and in cardiomyocytes.Examining the role of lipid mediators in diabetic retinopathy.D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injuryLipoxygenase metabolism: roles in tumor progression and survival.Endothelial cell regulation by phospholipid oxidation products.Redox signaling in cardiovascular health and disease.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Molecular biology of atherosclerosis.Transcriptional regulation of human UDP-glucuronosyltransferase genes.Ramadan fasting ameliorates oxidative stress and improves glycemic control and lipid profile in diabetic patients.The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy.Targeting of 12/15-Lipoxygenase in retinal endothelial cells, but not in monocytes/macrophages, attenuates high glucose-induced retinal leukostasis.Differential gene expression mediated by 15-hydroxyeicosatetraenoic acid in LPS-stimulated RAW 264.7 cells.Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2.The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene.PPARs and lipid ligands in inflammation and metabolism.
P2860
Q26996600-B74094F8-6C1F-40E5-A6AB-BE5324E2F44AQ27014988-FD640262-D2E7-4F5A-BF55-B11310DDA41EQ28248514-E4D25EE5-4918-4235-99D0-E3A1D9F9C6B9Q28296453-41828827-47BB-4E45-9317-ED10110DCB9EQ28388202-3D530E83-33BB-46E5-810A-DC6E854FBF37Q28396011-2EE654E6-FCA3-479A-8C1B-DBF0F40EC6DEQ28397861-8E4E719F-2E7C-4AA4-9610-DFCC581E4524Q29248910-5D88A09B-1954-4914-98AD-3E265E9FE55BQ30310826-725340BE-D665-4920-85A7-395E66256BBAQ30433351-8634C7AB-19AA-4ADF-A3D5-C07B4B88CC3EQ30434846-8F5843CC-E266-4EC7-A020-1CCDD8CE81BFQ30437150-8007D1EE-83D9-4D04-B9C4-76F05D3B7640Q30437845-00928BF0-1DBE-4541-A9F9-CE2200D5ADE7Q30438607-E44D6E84-0B42-4AA2-81B7-2BCF958745AEQ33226674-F2330605-CF3A-4E78-8537-87DEFB26F1F7Q33351784-292E2AF5-3C19-4F21-B731-872D68875782Q33750688-E344561C-DE41-427C-AF4B-C1EA2987BA99Q34137628-F1069256-2383-49DA-957D-49591DE6A26AQ34343723-B80F9C32-E796-440A-9E79-CDDF2F0E9102Q34385719-17D1BF34-2CDF-4E42-A660-1131B7ECBFD0Q34527211-127BB4ED-3857-4815-90A2-4DE7BBFF613FQ34566942-AB120C93-53CA-4255-83A3-78D7B14EFF8CQ36260399-01B39EFD-FE8A-4A07-8EA6-C8AB1B990E30Q36318247-5E075631-2669-4ADF-87FC-1327CA9B1D71Q36576553-69447A66-6E08-42D6-B4A2-C1DEBEC93C1CQ36808421-58E01C58-BB05-4412-8F5B-614DF41E51C6Q36860274-5A999E72-ABBA-42C0-905E-FEE470B53C4CQ36974347-15CDB1D8-C36E-4F15-8B23-FF79C4F2798AQ37156030-979E7426-7899-4D7B-A01F-E9A318BCE088Q37446110-41801C76-F1E0-45AE-89AD-C56B5CE08A2DQ37995534-7F72A06E-0A88-4F89-AD8A-AF77771F2B2DQ38125279-107D6FA9-0425-4173-86BC-E1D0D4E343BAQ38261875-90341DC0-18C4-4BB8-8AF9-B50175B81487Q38422663-40045E92-EF90-49C2-AB2B-5E9E744D30F3Q38622658-0489C81B-31EB-42EF-B1DA-8F5240745312Q38870510-B6CD5405-0501-49AB-8499-96D588F41D7BQ39813984-51634517-9AEC-4E7B-BEF7-47F9F27F0598Q39903564-1D0E41B6-DD99-4915-932E-31AEF8C3E1BAQ40671179-F3FFB0BC-6BB0-4035-B43A-ADC137E0D3FFQ41763780-9C4F3496-750F-4DAD-B7CC-682B73AE6BF6
P2860
Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells.
@en
type
label
Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells.
@en
prefLabel
Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells.
@en
P2093
P1476
Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells.
@en
P2093
Berliner JA
Hedrick CC
Natarajan R
Patricia MK
P304
P356
10.1161/01.ATV.19.11.2615
P407
P577
1999-11-01T00:00:00Z